NEUROCRINE BIOSCIENCES INC company mark
Healthcare · NYSE/NASDAQ: NBIX

NEUROCRINE BIOSCIENCES INC Annual Report 2026

AI-powered fundamental analysis, financial performance, quarterly earnings, management commentary, corporate governance, cash flow analysis and business intelligence for NEUROCRINE BIOSCIENCES INC.

Drug Manufacturers - Specialty & Generic
Market Cap $16.04B
NEUROCRINE BIOSCIENCES INC company mark

NEUROCRINE BIOSCIENCES INC Annual Report 2026

Official Filings · AI Report coming soon
Official Annual + Quarterly Filings
NASDAQ/NYSE: NBIX
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Market Cap $16.04B
Source: SEC EDGAR
Business Intelligence Report
Not generated yet

Quality Scores

Business
Compounder
Management
Governance
Cash Flow
AI Quality Scores locked
Sign In to Generate One →

Latest Quarterly Earnings Summary

No quarterly summary yet

Generate the Business Intelligence Report to unlock AI earnings summary.

Sign In to Generate One →
Loading latest Annual Report…

NEUROCRINE BIOSCIENCES INC Business Intelligence Hub

The NEUROCRINE BIOSCIENCES INC Business Intelligence Hub is your central gateway to AI-powered company research, fundamental analysis, and equity research on NEUROCRINE BIOSCIENCES INC. This page always opens the latest Business Intelligence annual report and stays in sync with NEUROCRINE BIOSCIENCES INC's newest 10-K filings, quarterly results and management commentary — so you're never reading stale analysis.

NEUROCRINE BIOSCIENCES INC Financial Performance & Statements

Explore NEUROCRINE BIOSCIENCES INC's financial statements, revenue growth, net profit, EPS, book value, free cash flow and net worth trends over 5 and 10 years — with deterministic AI-validated numbers, not hallucinated summaries.

NEUROCRINE BIOSCIENCES INC Quarterly Earnings & Management Commentary

Read the latest NEUROCRINE BIOSCIENCES INC quarterly results, earnings summary, management commentary and concall highlights — cross-checked against the official filing.

NEUROCRINE BIOSCIENCES INC Growth, Governance & Cash Flow Analysis

AI-graded scores on business compounding, compounder quality, management credibility, corporate governance and cash flow strength — the pillars of long-term business quality.

NEUROCRINE BIOSCIENCES INC Sector, Valuation & Risk Analysis

See NEUROCRINE BIOSCIENCES INC in context: sector analysis, industry analysis, competitive position, capital allocation, valuation context and key risks — surfaced from a decade of annual reports.

Related searches: NEUROCRINE BIOSCIENCES INC annual report, NEUROCRINE BIOSCIENCES INC AI annual report, NEUROCRINE BIOSCIENCES INC fundamental analysis, NEUROCRINE BIOSCIENCES INC business analysis, NEUROCRINE BIOSCIENCES INC financial performance, NEUROCRINE BIOSCIENCES INC financial statements, NEUROCRINE BIOSCIENCES INC growth analysis, NEUROCRINE BIOSCIENCES INC management analysis, NEUROCRINE BIOSCIENCES INC corporate governance, NEUROCRINE BIOSCIENCES INC cash flow analysis, NEUROCRINE BIOSCIENCES INC business intelligence, NEUROCRINE BIOSCIENCES INC valuation, NEUROCRINE BIOSCIENCES INC quarterly results, NEUROCRINE BIOSCIENCES INC earnings summary, NEUROCRINE BIOSCIENCES INC management commentary, NEUROCRINE BIOSCIENCES INC sector analysis, NEUROCRINE BIOSCIENCES INC company research, NEUROCRINE BIOSCIENCES INC equity research, NEUROCRINE BIOSCIENCES INC stock analysis, NEUROCRINE BIOSCIENCES INC AI company analysis, NEUROCRINE BIOSCIENCES INC capital allocation, NEUROCRINE BIOSCIENCES INC risk analysis, NEUROCRINE BIOSCIENCES INC competitive position, NEUROCRINE BIOSCIENCES INC long-term growth.